Key statistics
As of last trade NextCure Inc (NXTC:NSQ) traded at 12.85, -18.36% below its 52-week high of 15.74, set on Nov 24, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 12.60 |
|---|---|
| High | 13.26 |
| Low | 10.58 |
| Bid | 12.79 |
| Offer | 13.30 |
| Previous close | 12.72 |
| Average volume | 39.07k |
|---|---|
| Shares outstanding | 2.68m |
| Free float | 2.14m |
| P/E (TTM) | -- |
| Market cap | 34.09m USD |
| EPS (TTM) | -24.19 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 18:27 GMT.
More ▼
- NextCure Provides Business Update
- NextCure to Present at the Piper Sandler 37th Annual Healthcare Conference
- NextCure Announces Closing of $21.5 Million PIPE Financing in Advance of First Half 2026 Phase 1 POC Data Readouts
- NextCure Announces $21.5 Million Private Placement of Common Stock Priced at the Market Under Nasdaq Rules
- NextCure Provides Business Update and Reports Third Quarter 2025 Financial Results
- NextCure and Simcere Zaiming Announce Expansion of Ongoing Phase 1 Trial of SIM0505 (CDH6 ADC) into the United States
- NextCure to Present at the H.C. Wainwright 27th Annual Global Investment Conference
- NextCure Provides Business Update and Reports Second Quarter 2025 Financial Results
- Preclinical Data Demonstrate Anti-Siglec-15 Treatment Improves Bone Microarchitecture and Reduces Fracture Incidence in Mice with Moderate-to-Severe Osteogenesis Imperfecta
- NextCure and Simcere Zaiming Announce Strategic Partnership for a Novel Antibody-Drug Conjugate Targeting CDH6
More ▼
